NO20020029D0 - Fremgangsmåte for fremstilling av amilodipinbenzensulfonat - Google Patents

Fremgangsmåte for fremstilling av amilodipinbenzensulfonat

Info

Publication number
NO20020029D0
NO20020029D0 NO20020029A NO20020029A NO20020029D0 NO 20020029 D0 NO20020029 D0 NO 20020029D0 NO 20020029 A NO20020029 A NO 20020029A NO 20020029 A NO20020029 A NO 20020029A NO 20020029 D0 NO20020029 D0 NO 20020029D0
Authority
NO
Norway
Prior art keywords
amilodipine
benzenesulfonate
preparation
methyl
formula
Prior art date
Application number
NO20020029A
Other languages
English (en)
Other versions
NO321714B1 (no
NO20020029L (no
Inventor
Janos Fischer
Katalin Szoke
Laszlo Dobay
Sandor Levai
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of NO20020029D0 publication Critical patent/NO20020029D0/no
Publication of NO20020029L publication Critical patent/NO20020029L/no
Publication of NO321714B1 publication Critical patent/NO321714B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
NO20020029A 1999-07-05 2002-01-04 Fremgangsmate for fremstilling av amlodipinbenzensulfonat og farmasoytisk preparat omfattende dette, ftalamidinsyrederivat, forbindelse samt fremgangsmate for fremstilling av nye ftalamidinsyrederivater. NO321714B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/HU1999/000050 WO2001002360A1 (en) 1999-07-05 1999-07-05 Process for preparing amlodipine benzenesulphonate

Publications (3)

Publication Number Publication Date
NO20020029D0 true NO20020029D0 (no) 2002-01-04
NO20020029L NO20020029L (no) 2002-03-05
NO321714B1 NO321714B1 (no) 2006-06-26

Family

ID=10991279

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020029A NO321714B1 (no) 1999-07-05 2002-01-04 Fremgangsmate for fremstilling av amlodipinbenzensulfonat og farmasoytisk preparat omfattende dette, ftalamidinsyrederivat, forbindelse samt fremgangsmate for fremstilling av nye ftalamidinsyrederivater.

Country Status (24)

Country Link
US (1) US6596874B1 (no)
EP (1) EP1196383B1 (no)
JP (1) JP3764386B2 (no)
KR (1) KR100585442B1 (no)
CN (1) CN1141297C (no)
AT (1) ATE283841T1 (no)
AU (1) AU777565B2 (no)
BG (1) BG65657B1 (no)
CA (1) CA2376540C (no)
CZ (1) CZ300509B6 (no)
DE (1) DE69922417T2 (no)
DK (1) DK1196383T3 (no)
EA (1) EA004208B1 (no)
EE (1) EE05398B1 (no)
ES (1) ES2234272T3 (no)
HK (1) HK1044151B (no)
MX (1) MXPA01013407A (no)
NO (1) NO321714B1 (no)
NZ (1) NZ517013A (no)
PL (1) PL194193B1 (no)
PT (1) PT1196383E (no)
SK (1) SK285611B6 (no)
UA (1) UA72768C2 (no)
WO (1) WO2001002360A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100354806B1 (ko) * 2000-06-21 2002-10-05 한국유나이티드제약 주식회사 암로디핀 베실레이트의 신규 중간체 및 그의 제조방법
EP1435954B1 (en) * 2001-07-06 2010-01-13 LEK Pharmaceuticals D.D. A PROCESS FOR THE PREPARATION OF HIGHlLY PUREAMLODIPINE BENZENESULFONATE
US6680334B2 (en) 2001-08-28 2004-01-20 Pfizer Inc Crystalline material
US6828339B2 (en) * 2001-11-21 2004-12-07 Synthon Bv Amlodipine salt forms and processes for preparing them
KR100496436B1 (ko) * 2002-07-30 2005-06-20 씨제이 주식회사 암로디핀의 유기산염
KR100462304B1 (ko) * 2002-07-30 2004-12-17 씨제이 주식회사 암로디핀의 유기산염
KR100467669B1 (ko) * 2002-08-21 2005-01-24 씨제이 주식회사 암로디핀의 유기산염
US6784297B2 (en) 2002-09-04 2004-08-31 Kopran Limited Process for the preparation of anti-ischemic and anti-hypertensive drug amlodipine besylate
JP2008013489A (ja) * 2006-07-06 2008-01-24 Ohara Yakuhin Kogyo Kk ベシル酸アムロジピン含有錠剤
EP1975167A1 (en) 2007-03-30 2008-10-01 Esteve Quimica, S.A. Acetone solvate of phthaloyl amlodipine
CN101812014B (zh) * 2010-04-28 2011-08-24 王明 一种苯磺酸氨氯地平化合物及其制法
CN102993083A (zh) * 2012-12-21 2013-03-27 王学军 一种苯磺酸氨氯地平的制备方法
CN104262237A (zh) * 2014-09-28 2015-01-07 常州瑞明药业有限公司 氨氯地平自由碱的合成方法
US11452690B1 (en) 2021-01-27 2022-09-27 ECI Pharmaceuticals, LLC Oral liquid compositions comprising amlodipine besylate and methods of using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161312C (da) * 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
GB8608335D0 (en) * 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
SI9200344B (sl) 1992-11-26 1998-06-30 Lek, Postopek za pripravo amlodipin benzensulfonata
HU221810B1 (hu) * 1997-08-12 2003-01-28 EGIS Gyógyszergyár Rt. Eljárás amlodipin-bezilát előállítására és az eljárás intermedierjei
DE19738943B4 (de) 1997-09-05 2008-01-03 Siemens Ag Verfahren und Einrichtung zur Bestimmung von Eigenschaften eines Stahls

Also Published As

Publication number Publication date
EA004208B1 (ru) 2004-02-26
JP2003503477A (ja) 2003-01-28
CA2376540A1 (en) 2001-01-11
EE05398B1 (et) 2011-04-15
JP3764386B2 (ja) 2006-04-05
CN1141297C (zh) 2004-03-10
EA200200125A1 (ru) 2002-06-27
CZ300509B6 (cs) 2009-06-03
EE200100686A (et) 2003-04-15
NO321714B1 (no) 2006-06-26
CN1352634A (zh) 2002-06-05
ATE283841T1 (de) 2004-12-15
CZ20014690A3 (cs) 2002-04-17
EP1196383B1 (en) 2004-12-01
WO2001002360A1 (en) 2001-01-11
KR20020022760A (ko) 2002-03-27
HK1044151B (zh) 2004-09-10
HK1044151A1 (en) 2002-10-11
SK22002A3 (en) 2002-05-09
NZ517013A (en) 2003-08-29
DK1196383T3 (da) 2005-02-21
PT1196383E (pt) 2005-03-31
BG106164A (en) 2002-07-31
BG65657B1 (bg) 2009-05-29
MXPA01013407A (es) 2003-09-04
ES2234272T3 (es) 2005-06-16
AU4923799A (en) 2001-01-22
DE69922417T2 (de) 2005-12-01
KR100585442B1 (ko) 2006-06-02
PL194193B1 (pl) 2007-05-31
CA2376540C (en) 2007-03-13
EP1196383A1 (en) 2002-04-17
SK285611B6 (sk) 2007-04-05
AU777565B2 (en) 2004-10-21
PL352493A1 (en) 2003-08-25
US6596874B1 (en) 2003-07-22
NO20020029L (no) 2002-03-05
UA72768C2 (en) 2005-04-15
DE69922417D1 (de) 2005-01-05

Similar Documents

Publication Publication Date Title
NO20020029D0 (no) Fremgangsmåte for fremstilling av amilodipinbenzensulfonat
ES2195510T3 (es) Derivados de imidazopiridina y procedimiento para prepararlos.
IS6435A (is) Aðferð til framleiðslu á sítalóprami
NO20002589D0 (no) Bifenylamidinderivater
DK1127886T3 (da) Syntese af 3,6-dialkyl-5,6-dihydro-4-hydroxy-2H-pyran-2-on
NO20040388L (no) Fremgangsmåte for fremstilling av beraprost og salter derav, samt forbindelser som er mellomprodukter i fremgangsmåten
YU76500A (sh) Hemijska sinzeza morfolinskih derivata
DK1206452T3 (da) Fremgangsmåde til fremstilling af benzoperhydro-isoindolforbindelser
DK1105392T3 (da) Fremgangsmåde til fremstilling af mellemprodukter for imidazodiazepin
NO20052197L (no) Fremgangsmate for fremstilling av pyrazol
NO20053712L (no) Fremgangsmate for fremstilling av substituerte imidazolderivater og mellomprodukter anvendt i fremgangsmaten
DK1347965T3 (da) Hidtil ukendte desloratidinsalte, fremgangsmåde til syntese deraf samt farmaceutiske præparater deraf
NO20026198D0 (no) Cykliske ketoner, deres fremstilling og deres anvendelse ved syntese av aminosyrer
TR200003360T2 (tr) Farmasotik norbenzomorfan türevleri imalatı için iyileştirilmiş yöntem
DE60127979D1 (de) Verfahren zur herstellung von 3,5-bisalkylphenolen
DK1320527T3 (da) Fremgangsmåde til fremstilling af 1-substituerede 5-chlor-4-methylpytrazoler
HUP0002772A2 (hu) Eljárás királis 3,4-dehidroprolinok előállítására
DK1392652T3 (da) Fremgangsmåde til fremstilling af 1,3-disubstituerede 2-nitroguanidiner
DK1242390T3 (da) Fremgangsmåde til fremstilling af 1,3-disubstituerede 2-nitroguanidiner

Legal Events

Date Code Title Description
MK1K Patent expired